Cooper Companies (NASDAQ:COO) Hits New 52-Week Low – What’s Next?

The Cooper Companies, Inc. (NASDAQ:COO)’s share price reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as $58.91 and last traded at $58.98, with a volume of 1696336 shares changing hands. The stock had previously closed at $60.00.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. Citigroup dropped their price target on shares of Cooper Companies from $88.00 to $87.00 and set a “neutral” rating on the stock in a research report on Friday, March 6th. Rothschild & Co Redburn downgraded shares of Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price target on the stock. in a research report on Wednesday, March 4th. William Blair upgraded shares of Cooper Companies to a “strong-buy” rating in a research report on Friday, January 30th. Barclays boosted their price target on shares of Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, March 6th. Finally, Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Saturday, February 28th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $90.79.

Cooper Companies Price Performance

The company has a current ratio of 1.34, a quick ratio of 0.79 and a debt-to-equity ratio of 0.22. The business’s fifty day moving average is $70.21 and its 200 day moving average is $75.86. The firm has a market capitalization of $11.51 billion, a P/E ratio of 29.20, a P/E/G ratio of 1.55 and a beta of 0.89.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, topping analysts’ consensus estimates of $1.03 by $0.07. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The business had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.02 billion. During the same period in the previous year, the firm earned $0.92 EPS. The business’s revenue for the quarter was up 6.2% on a year-over-year basis. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. As a group, analysts forecast that The Cooper Companies, Inc. will post 4.62 EPS for the current year.

Institutional Trading of Cooper Companies

A number of hedge funds and other institutional investors have recently made changes to their positions in COO. Wellington Management Group LLP raised its holdings in shares of Cooper Companies by 332.9% in the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after purchasing an additional 4,756,178 shares in the last quarter. Generation Investment Management LLP bought a new stake in shares of Cooper Companies in the 4th quarter worth approximately $233,539,000. Diamond Hill Capital Management Inc. raised its holdings in shares of Cooper Companies by 479.6% in the 4th quarter. Diamond Hill Capital Management Inc. now owns 3,287,837 shares of the medical device company’s stock worth $269,471,000 after purchasing an additional 2,720,594 shares in the last quarter. JANA Partners Management LP bought a new stake in shares of Cooper Companies in the 3rd quarter worth approximately $166,917,000. Finally, Price T Rowe Associates Inc. MD raised its holdings in shares of Cooper Companies by 58.8% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after purchasing an additional 2,231,568 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.